Biol stock forecast.

BIOL Stock Forecast, Price & News (BIOLASE) - MarketBeat WebJan 17, 2023 · BIOLASE (NASDAQ:BIOL) has a market capitalization of $3.32 million and generates $39.19 million in revenue each year. The medical technology company earns $-16,160,000.00 in net income (profit) each year or ($3.57) on an earnings per share basis.Cathie Wood. Brendan McDermid/Reuters. Ark Invest CEO Cathie Wood expects synthetic-biology companies to take off in the next five years. "There is going to be explosive growth that most people in ...Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Stock Forecast Currrency forecast Cryptocurrency forecast Blog All stock predictions Overall outlook for BIOLASE stock Tomorrow Week Month 2023 2024 2025 2026 2027 …

See the latest Biolase Inc stock price (BIOL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.218.18%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -55.91M. 21.33%. Get the latest Immunitybio Inc (IBRX) real ...

According to the issued ratings of 2 analysts in the last year, the consensus rating for BIOLASE stock is Buy based on the current 2 buy ratings for BIOL. The …If you are thinking about buying BIOL, make sure you check out the free BIOL stock predictions report provided by MarketClub. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how BIOL will perform in the near future. You will get a free BIOL forecast report will be ...

Target values for the price of one BIOLASE share for Dec 2023. The weighted average target price per BIOLASE share in Dec 2023 is: 1.25. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 22.163% volatility is expected. Pessimistic target level: 1.08. Optimistic target level: 1.39.Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67. Oct 26, 2021 · For BIOLASE stock forecast for 2031, 12 predictions are offered for each month of 2031 with average BIOLASE stock forecast of $1.91, a high forecast of $3.64, and a low forecast of $0.72. The average BIOLASE stock forecast 2031 represents a 66.26% increase from the last price of $1.14999997615814. For BIOLASE stock forecast for 2033 (10 year ... Get The Latest SYN Stock Analysis, Price Target, Earnings Estimates, and Headlines at MarketBeat. ... In Vitro Toxicology Testing Market Global Forecast to 2028. November 17, 2023 | finance.yahoo.com ... Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA.

Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Nov 13, 2023 · High Growth Earnings: BIOL is forecast to remain unprofitable over the next 3 years. Revenue vs Market: BIOL's revenue (10% per year) is forecast to grow faster than the US market (8% per year). High Growth Revenue: BIOL's revenue (10% per year) is forecast to grow slower than 20% per year. allforecast.comDec 1, 2023 · Detailed statistics for BIOLASE, Inc. (BIOL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average ... Price Target. Based on short-term price targets offered by three analysts, the average price target for Biolase comes to $15.67. The forecasts range from a low of $3.00 to a high of $40.00. The ...Nasdaq | BIOL U.S.: Nasdaq Biolase Inc. Watch list Set a price target alert After Hours Last Updated: Nov 24, 2023 4:47 p.m. EST Delayed quote $ 1.2400 0.00 0.00% After Hours …

BIOL Stock Predictions, Articles, and Biolase Inc News From InvestorPlace From the Web Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday By William White ...Adecoagro ( NYSE:AGRO ) $1.1 billion. A South American farming operation, including production of wheat. 1. Deere and Co. Deere and Co., better known as John Deere, is one of the most iconic U.S ...Get The Latest MRNA Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. ... 294th out of 957 stocks. Biological Products, Except Diagnostic Industry. 46th out of 158 stocks. 4.1 Analyst's Opinion. ... View our MRNA earnings forecast.BIOLASE Stock Forecast 20 Oct. Presumably, on 10/20/2023, the price of shares will be in the range of $1.76 - $1.88. A $0.11 range width can provide 6.53% volatility. The weighted average price of this range is at $1.82, which is $0.02 higher than the previous day's weighted average price.Nov 14, 2023 · Target values for the price of one BIOLASE share for Dec 2023. The weighted average target price per BIOLASE share in Dec 2023 is: 1.25. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 22.163% volatility is expected. Pessimistic target level: 1.08. Optimistic target level: 1.39.

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.Nov 14, 2023 · Target values for the price of one BIOLASE share for Dec 2023. The weighted average target price per BIOLASE share in Dec 2023 is: 1.25. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 22.163% volatility is expected. Pessimistic target level: 1.08. Optimistic target level: 1.39.

BIOL Sales Forecast. Next quarter’s sales forecast for BIOL is $14.75M with a range of $13.35M to $16.70M. The previous quarter’s sales results were $10.92M. BIOL beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.34% of the time in the same period. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -7.46M. 45.53%. Get the latest Generation Bio Co (GBIO) real-time quote, historical ...Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Starting us off today is Twist Biosciences. In brief, Twist is a leading name in the synthetic biology industry today. The company’s core work revolves around its proprietary DNA synthesis ...Find real-time BLUE - bluebird bio Inc stock quotes, company profile, news and forecasts from CNN Business.Biolase, Inc. (BIOL) stock forecast and price target. Find the latest Biolase, Inc. BIOL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

218.18%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -55.91M. 21.33%. Get the latest Immunitybio Inc (IBRX) real ...

Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Cathie Wood. Brendan McDermid/Reuters. Ark Invest CEO Cathie Wood expects synthetic-biology companies to take off in the next five years. "There is going to be explosive growth that most people in ...BIOL's price to book (P/B) is 81% more than its last 4 quarters average of 2.0 but 38% less than its 5-year quarterly average of 5.8 The stock's price to sales (P/S) is 97% less than its 5-year quarterly average of 1.0 and 70% less than its last 4 quarters average of 0.1Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...Nov 26, 2023 · BIOLASE, Inc. (BIOL) share price prediction for 2023, 2024, 2025, 2026 and 2027. BIOL one year forecast. Biolase stock monthly and weekly forecasts. The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ...4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price.Detailed statistics for BIOLASE, Inc. (BIOL) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The average ...COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023. LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's stockholders granted the Board of Directors the discretion to effect a ...

BIOL Stock 12 Months Forecast. $22.00. (1659.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average …The value each BIOL share was expected to gain vs. the value that each BIOL share actually gained. BIOLASE ( BIOL) reported Q2 2023 earnings per share (EPS) of -$8.93, missing estimates of -$5.33 by 67.48%. In the same quarter last year, BIOLASE 's earnings per share (EPS) was -$90.62. BIOLASE is expected to release next earnings on -, with an ... Zymergen, which describes itself as a “biofacturing company using biology to reimagine the world,” plunged 68% in extended trading on Tuesday to $11.07, down from its IPO price of $31. The ...Instagram:https://instagram. jones transportunilver stockapptech stockfamous forex brokers Find real-time BIO - Bio Rad Laboratories Inc stock quotes, company profile, news and forecasts from CNN Business. how to buy altcoinshome insurance companies that allow pit bulls Stock Forecast Currrency forecast Cryptocurrency forecast Blog All stock predictions Overall outlook for BIOLASE stock Tomorrow Week Month 2023 2024 2025 2026 2027 …BIOL's price to book (P/B) is 81% more than its last 4 quarters average of 2.0 but 38% less than its 5-year quarterly average of 5.8 The stock's price to sales (P/S) is 97% less than its 5-year quarterly average of 1.0 and 70% less than its last 4 quarters average of 0.1 bulletshares bond ladder Among DNA stocks, Twist Bioscience (NASDQ: TWST) stands above the rest in terms of price. It offers to sell DNA at a cost as low as 7 cents per base pair, far below competitors like Genscript ...According to . 1 Wall Street analyst that have issued a 1 year BIOL price target, the average BIOL price target is $40.00, with the highest BIOL stock price forecast at $40.00 and the lowest BIOL stock price forecast at $40.00. Find the latest BridgeBio Pharma, Inc. (BBIO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...